Concentration Determination of >200 Proteins in Dried Blood Spots for Biomarker Discovery and Validation

Abstract

The use of protein biomarkers as surrogates for clinical endpoints requires extensive multilevel validation including development of robust and sensitive assays for precise measurement of protein concentration. Multiple reaction monitoring (MRM) is a well-established mass-spectrometric method that can be used for reproducible protein-concentration measurements in biological specimens collected via microsampling. The dried blood spot (DBS) microsampling technique can be performed non-invasively without the expertise of a phlebotomist, and can enhance analyte stability which facilitate the application of this technique in retrospective studies while providing lower storage and shipping costs, because cold-chain logistics can be eliminated. Thus, precise, sensitive, and multiplexed methods for measuring protein concentrations in DBSs can be used for de novo biomarker discovery and for biomarker quantification or verification experiments. To achieve this goal, MRM assays were developed for multiplexed concentration measurement of proteins in DBSs.The lower limit of quantification (LLOQ) was found to have a median total coefficient of variation (CV) of 18% for 245 proteins, whereas the median LLOQ was 5 fmol of peptide injected on column, and the median inter-day CV over 4 days for measuring endogenous protein concentration was 8%. The majority (88%) of the assays displayed parallelism, whereas the peptide standards remained stable throughout the assay workflow and after exposure to multiple freeze-thaw cycles. For 190 proteins, the measured protein concentrations remained stable in DBS stored at ambient laboratory temperature for up to 2 months. Finally, the developed assays were used to measure the concentration ranges for 200 proteins in twenty same sex, same race and age matched individuals. The use of protein biomarkers as surrogates for clinical endpoints requires extensive multilevel validation including development of robust and sensitive assays for precise measurement of protein concentration. Multiple reaction monitoring (MRM) is a well-established mass-spectrometric method that can be used for reproducible protein-concentration measurements in biological specimens collected via microsampling. The dried blood spot (DBS) microsampling technique can be performed non-invasively without the expertise of a phlebotomist, and can enhance analyte stability which facilitate the application of this technique in retrospective studies while providing lower storage and shipping costs, because cold-chain logistics can be eliminated. Thus, precise, sensitive, and multiplexed methods for measuring protein concentrations in DBSs can be used for de novo biomarker discovery and for biomarker quantification or verification experiments. To achieve this goal, MRM assays were developed for multiplexed concentration measurement of proteins in DBSs. The lower limit of quantification (LLOQ) was found to have a median total coefficient of variation (CV) of 18% for 245 proteins, whereas the median LLOQ was 5 fmol of peptide injected on column, and the median inter-day CV over 4 days for measuring endogenous protein concentration was 8%. The majority (88%) of the assays displayed parallelism, whereas the peptide standards remained stable throughout the assay workflow and after exposure to multiple freeze-thaw cycles. For 190 proteins, the measured protein concentrations remained stable in DBS stored at ambient laboratory temperature for up to 2 months. Finally, the developed assays were used to measure the concentration ranges for 200 proteins in twenty same sex, same race and age matched individuals. Blood is the most used biofluid for clinical tests and for research purposes, as it can often indicate the health status of an individual. Although the most common method of blood collection is venipuncture, microsampling methods, requiring <100 μl of blood, such as capillary blood sampling, are gaining acceptance (1Lim M.D. Dried blood spots for global health diagnostics and surveillance: opportunities and challenges.Am. J. Trop. Med. Hyg. 2018; 99: 256-265Crossref PubMed Scopus (39) Google Scholar). The dried blood spot (DBS) 1The abbreviations used are:DBSdried blood reaction limit of of 1The abbreviations used are:DBSdried blood reaction limit of of microsampling technique found to be for and in research as the total of a of methods and including and of the in dried blood 2018; PubMed Scopus Google Scholar). DBSs are used in for of of and in J. status of PubMed Scopus Google Scholar). The of DBS collection of blood and capillary which can be performed without the of a phlebotomist, and the of the logistics of shipping storage which to a in dried blood spot Multiple reaction monitoring lower limit of quantification stable of dried blood spot Multiple reaction monitoring lower limit of quantification stable of the DBS the application is the of endogenous analyte The that to be for is the in the blood in the of which can the concentrations of the Dried blood spots and in PubMed Scopus Google de of the for the use of DBS in the the PubMed Scopus Google and 2018; PubMed Scopus Google of and on of dried blood spots for J. PubMed Scopus Google blood for PubMed Scopus Google The use of to dried blood PubMed Scopus Google J. The of dried blood spots for to PubMed Scopus Google and for the validation of methods dried blood a PubMed Scopus Google and opportunities in of proteins dried blood PubMed Scopus Google the an in dried blood spot PubMed Scopus Google Scholar). DBS a in because the in protein of PubMed Scopus Google which can J. Multiple reaction monitoring precise quantification of proteins in dried blood PubMed Scopus Google reaction monitoring of and in dried blood PubMed Scopus Google Scholar). the and the can be for that are the in matched blood and DBS Blood on for and Scholar). The for the multiplexed measurement of protein concentration in DBSs is the of protein which in Multiple reaction monitoring (MRM) is a technique which multiplexed assays for proteins in and stable PubMed Scopus Google and to measure protein concentration in DBS J. Multiple reaction monitoring precise quantification of proteins in dried blood PubMed Scopus Google J. of endogenous proteins in dried blood spots multiple reaction PubMed Scopus Google Scholar). the the and of MRM assay of MRM assays to and in including biomarker validation and discovery J. a of PubMed Scopus Google Scholar). The a J. J. J. J. J. J. peptide measurements in and for assay development a PubMed Scopus Google in which biomarker discovery in requiring a to a of the use of standards for of and the application of biomarkers is for use in that can measure protein as to be for concentration ranges and that in a clinical be for J. for the of in without for the of in without of the of J. PubMed Scopus Google clinical and PubMed Scopus Google Scholar). The of was to a method for measuring the concentrations of proteins in that the assay 2 for the precise quantification of endogenous proteins in DBS J. Multiple reaction monitoring precise quantification of proteins in dried blood PubMed Scopus Google Scholar). on that the protein of the assay to 200 proteins and the validation at the lower limit of quantification the of the for analyte in biological and performed extensive stability of standards and endogenous for analyte were to for and to the for Finally, the of the assays was the biological for protein measuring of protein concentration in a of individuals. blood was collected at a blood the that the blood be used for research purposes, without the Blood was collected The of for blood for the is blood was and 4 were to 5 of blood which was collected Blood were and without and were used to DBS after collection of Dried blood spots capillary blood were The was of DBS were to Dried blood spot collection of health biomarkers to in Scholar). for to blood the on the was an and to and this was performed The was and the to facilitate blood The was and and the while the the to to blood the was used to the to the to the of the or to the for the of the The of blood was a to that be because of of the the a capillary blood collection μl was used to μl of of blood a was used to spot μl of blood spot on a Blood spots were dried at ambient temperature and for exposure to and were in a a an were at ambient temperature and MRM days after the of the DBS DBSs were for and a spot displayed or of it was DBS were a were performed spot or were collected in a and μl μl of was the was for at at an were for to the and and was used to 200 μl to a of was and the was at for at on an were at μl of an was and the were at for in the a μl of the was to a and μl of in was was in a for at at μl of was to the and to the was at for and μl of the was to a this the was to be peptide standards to was for the used to the DBS which up to the of were to a To μl of DBS μl of in was and was in an at for at To the and the μl of was to the reaction The was for at to the and and the was to a and for to the the The was used for the for the were for MRM assay development on in and were of DBS the were to Multiple reaction monitoring peptide standards for protein 2018; PubMed Scopus Google and were in μl of in and used for on an to an via a as of laboratory multiple reaction monitoring 2018; PubMed Scopus Google J. assays for the of proteins in and Scholar). The was to μl of which was to of total were and The were as of laboratory multiple reaction monitoring 2018; PubMed Scopus Google the the were to and the the protein PubMed Scopus Google which protein The was to to The was to and were as and and were at and validation was performed the to and at for and validation on were for MRM assay development for and on protein concentrations in biological Scopus Google for MRM stable this proteins proteins multiple were were for MRM assay MRM of the MRM assay was performed on an to a via a The was a and an was performed up a at a of The were in and in The was as 4 was to 4 and the was to The was at were performed a and and were used for MRM as at a of the was to at 4 the was to the and at the was to μl of was was after DBS to the of were μl of to the capillary the and for the was to The MRM method for a is in The were as temperature temperature capillary and for and was and for and for was 200 for and for and was and for and was performed of and peptide the and performed the limit of variation which was at a CV for measured for peptide the of for peptide measurements was was performed as J. Multiple reaction of proteins in PubMed Scopus Google Scholar). were or on the were and the to an The of peptide was capillary on a as J. Multiple reaction of proteins in PubMed Scopus Google of assays for the of PubMed Scopus Google and the concentration of peptide was measured J. M.D. J. of in dried blood 2018; PubMed Scopus Google Scholar). peptide standards were and the were J. M.D. J. of in dried blood 2018; PubMed Scopus Google and to in MRM was performed a or for and quantification of the were performed as without of For of the or which were via and the or which via and were used to measure the concentration of the The of the MRM was performed an for and PubMed Scopus Google the of and a to of and PubMed Scopus Google Scholar). the were for of on the measurement of reaction monitoring PubMed Scopus Google and a was for a were monitoring and 2 5 and were the DBS a DBS and the of and was used to the of endogenous peptide via and to to an the the peptide for protein are in The for the same peptide is for To assay the used to peptide was as of proteins in blood multiplexed multiple reaction monitoring PubMed Scopus Google Scholar). the used for the for in an for and PubMed Scopus Google was used to a MRM The MRM method was used to a method the to 5 and the to on of the at The which the for was used for methods To were for assay development The used for the over because the is in used in a J. in and PubMed Scopus Google the to and which displayed the and of a J. a of PubMed Scopus Google was used as a to the lower limit of quantification (LLOQ) for to DBS the of laboratory multiple reaction monitoring 2018; PubMed Scopus Google J. assays for the of proteins in and was used to an to a to the The to be were used to of of peptide in The of peptide was used to a for an the concentration to of peptide injected on the the was were for use as for 245 For the peptide was the endogenous was used as a the was without measuring the coefficient of variation the to the to be used for the were in and was 2 μl of a the and 2 μl of the in to μl of DBS was injected for MRM and were the and was used for quantification of the LLOQ and for assay were an for and PubMed Scopus Google the of the peptide as the for The was to and the was to The was to 2 and the limit of was to The in was used to For to the the were at the the the or at the The of the to was the fmol of peptide injected on of was used as the for an assay to be were to and the coefficient of variation (CV) was at The LLOQ was the of the or without which was on the which the lower The a CV of was as the For for which an LLOQ was on the a of was 2 J. a of PubMed Scopus Google as a was the of laboratory multiple reaction monitoring 2018; PubMed Scopus Google J. assays for the of proteins in and which the concentration and endogenous as or the peptide without for for which the peptide was or the endogenous peptide was to the DBS was used for the which be used to the limit of as the measured the was fmol to fmol of peptide injected on and were in a as DBS and and was injected for multiplexed a peptide same was as was used for the were on at MRM and were performed as in the endogenous or without were used for the of to the were the at concentration on and The were the on and was performed for and the were and used as the The total variation was as the of of the and assay CV was a measure of the of the MRM was the J. a of PubMed Scopus Google DBSs the capillary blood of were as for MRM assay was of the a of which as the The on was the of endogenous and were DBS of The of the was a of the endogenous peptide The of the to fmol injected on was fmol to fmol for the fmol to fmol for the and fmol to fmol for the The in was to the without a as the and were as The of the in was of the in to the the and or the and on which a The for the of the was the The for of were to a in the the was to for in the of peptide the which an in the of To measure the the as measured in were to was as the and the were the The was the the of the for concentration were and the were used to the in the The for that the of the in an be of the of the The to this is that MRM assays which have a of a of the in an that the and assays be To this assays were to be the of the in of the was of the or the assay was of the The the in a the was as a is the or the of was of a in of the and was to be the of the of the and the and endogenous was performed in the 4 J. a of PubMed Scopus Google Scholar). The DBS as was and that the of fmol to fmol and 2 fmol to fmol were injected on were in and of the were in the which was at 5 while the were stored at of the on the was injected in a total of MRM which be to as the after the of the the same was and the MRM were and used as after the of the the MRM and was for of the the stored at were at were at while the were used for MRM as were and as a freeze-thaw The which in the were a and as as freeze-thaw The were 4 and as The for in 4 that in the in measured at the or the in The were endogenous as the in and were the which was as is the or the of was of a in of the at and was the of the blood and were and used to spots on protein was on and spot was for MRM The the blood to the MRM of protein over was performed in total of in in 5 J. a of PubMed Scopus Google Scholar). of for a of proteins was to in the a validation of was performed method validation for of and and for and for for of of for and and 2018; Google DBS spots as the spot was the the the and the and were for validation was performed a protein in to over a total of for of and was as were measured the as the and endogenous peptide as the were which were used for MRM total were and the CV was the for on The 4 days were to the The inter-day CV was as the for were The of on was used to an inter-day and the same was performed for the The inter-day were to an inter-day The total variation was as the of the and inter-day stability in DBSs was at and up to days of storage to 5 was used to spot spots of protein μl of blood spot and a total of was in a and were in and stored at ambient laboratory temperature or of temperature was and as and measured at be this to a protein concentration a after The measured were and measured at were the which was as is the or the 2 was of a in of the at and the of the for DBS MRM assay was to the fmol of peptide measured on a DBS to a concentration in To MRM assays were performed to measure endogenous in blood, and blood blood was used to DBSs μl or μl of blood on protein in blood in the was μl to μl of in in μl of blood was in The DBSs were used to a whereas the DBS spots were spot was without to in μl of the blood were μl of were for MRM as in the were in as in the and the endogenous were used to the The measured in blood was the in DBS and to a for MRM the MRM were for the spot and for DBS Finally, to the a the was the the the of protein concentration of blood the concentration measurement was performed a a DBS The of this is that on be blood be a capillary The was performed blood to the was the to the concentration measurements that was in DBS to blood The concentrations of the endogenous were measured the for the in a The in the The was on the and the concentration on the the peptide concentration was to a of of the concentration of endogenous peptide The peptide was used to a to a a the endogenous peptide concentration were the and to and the of the and the endogenous the fmol of endogenous peptide injected on can be for an Finally, the concentration of the peptide in the blood can be the for as in the of of the and collection of capillary blood are in the on collection of blood and DBS were days after collection capillary blood as as in the on MRM was performed on and the measured protein concentration was the of MRM the in a to a assay for proteins proteins were for MRM assay development on in DBSs and the on studies which used of blood, such as blood or in DBSs were without of proteins, a workflow via which proteins The of protein was to proteins on studies which of proteins and to to health and PubMed Scopus Google of blood PubMed Scopus Google Scholar). to a of and proteins were for and on protein concentrations in biological Scopus Google which the of protein to proteins, Thus, the of proteins for MRM assay development was for and peptide The LLOQ and the of for the were in a DBS on the of laboratory multiple reaction monitoring 2018; PubMed Scopus Google J. assays for the of proteins in and the concentration of stable is and the endogenous are used as was over a of of and a was the was and CV was used to the which are in as a the of peptide at concentration were for of the concentrations as as a median of 4 and of fmol injected on The for which an LLOQ be were for assay MRM assay at the LLOQ was for the MRM assays for which an LLOQ was was on the of and inter-day The total CV was as the of the and inter-day was at the LLOQ and at concentrations to of and for MRM to proteins, a concentration at which the total CV was be and and The of the assays is in as a of the measured the MRM the median and total at the LLOQ were and a of The measured are in as a of the of MRM assays and the The median LLOQ the MRM assays was 5 fmol of peptide injected on column, and of the MRM assays of fmol injected on column, whereas the and measured were fmol and fmol of peptide injected on The which a total CV of at were for assay and was performed DBS individuals. was in of the DBS as the and the concentration of The in was the endogenous for a The of the the was to assay was as the measured an the was for MRM assays assays for which was to proteins, of which MRM assays displayed as and The assays which were found to be were for assay development and the of and it be be the of a DBS for MRM and were used to storage on the or storage in the assay was the in the endogenous or endogenous peptide at to the at in of was to indicate that the endogenous were stable on the after exposure to cycles. and for the MRM assays the of and of DBS for MRM and for 4 the MRM assays of and DBSs were blood, and and were for MRM assays of endogenous that proteins be and proteins be of the quantification of the endogenous used for quantification of the endogenous proteins, that proteins be an CV of proteins an inter-day CV of and proteins a total CV of as the of of the and inter-day 4 and The stability of proteins in DBSs stored at ambient laboratory at and at was for up to days to cold-chain logistics be for shipping DBS of the endogenous to MRM assay that of the proteins were stable for days stored at ambient laboratory temperature and at and up to days stored at in a 2 that the endogenous at the was 2 the endogenous measured at in be to the of the assay and to the stability of the a of was an that protein stability To concentration of protein of blood to DBS were to the concentration in DBSs to in blood of endogenous for in matched blood and DBSs in the a of and a and of and To the the matched blood and were used to the endogenous the in endogenous in a of and a and of and of DBSs blood endogenous to a of and a and of and which that to was the in the of endogenous in DBS and blood were for endogenous the to were in that the have protein DBSs the concentration measurements were performed which were in a and peptide standards as the and were for the quantification of the of the to The of the was the concentration of and the of used to of which are as in in displayed a peptide concentration of up to of median of and and of and measured the concentrations of used for concentrations of were as in median of and and of and The of used for is in which a median of a of and a of and the concentration ranges of protein were capillary blood DBSs a of of protein concentrations in capillary blood of concentration ranges proteins of as as in protein concentrations The are on the same for and that the majority of protein were protein were found at endogenous The of the developed MRM assays was the measured protein concentration the over the and the which were MRM can be that the protein concentration ranges were the measured the MRM assay was to protein concentration and individuals. protein concentration is in and a median concentration for a protein of a of and a of The proteins that displayed a of in concentration are in The of the was to assays for precise and multiplexed protein concentration measurements DBS and to concentration ranges in a of age same sex, and same race individuals. The median lower limit of quantification was 5 fmol on column, to fmol of protein μl of to of blood, the median LLOQ was to or for proteins of 5 and The LLOQ measured was fmol on which a limit of quantification to of protein in For the protein concentrations in for proteins, and proteins are and The and PubMed Scopus Google biomarker discovery PubMed Scopus Google Scholar). Thus, the of MRM on DBS the measurement of protein concentrations of and proteins, to the the MRM assays displayed over a concentration of the concentration in this for the or biological was the of the of the MRM assays was the which to protein concentrations in a same same sex, and age on it be to use MRM assays for measuring protein concentrations in DBSs to ranges in and or and for that and individuals. MRM assays were measuring the in DBS and the stability of peptide standards and storage in a the MRM assays be for parallelism, because of the of at the were the assays for parallelism, the majority displayed parallelism, that the assays were and which that the concentration measurements of the proteins be and of the The peptide standards were found to be stable throughout the assay workflow and for up to 2 days on the at 5 and after multiple cycles. in was after 4 storage at which was in to of the as was a measured at that to of the of DBS is the in analyte stability which can in of the concentration of the analyte measured in blood, and shipping and storage shipping and in and of the DBS Although proteins are stable in dried in the in protein of PubMed Scopus Google that in to measured protein concentrations the same measured in blood DBSs. of endogenous peptide concentrations measured in matched blood and DBS in an concentration DBSs. the matched blood and blood in concentration measurements in the was that the was the that to in protein of the endogenous this and for of the endogenous the concentrations were in blood matched DBS and that protein after the to concentration on are in to concentrations of blood measurements are in The were for protein in to for for in and the endogenous protein concentrations were measured MRM which were a while the concentration. were the because the the in was is a of are J. J. method for in 2018; Google Scholar). at ambient laboratory at and at the that the proteins remained stable in the DBS at at for in in that proteins displayed concentrations at that storage or exposure of DBS to over the of in concentration because of exposure of DBS to on the logistics can be for the shipping and storage of DBS For storage up to 2 ambient laboratory temperature to the 200 MRM assays have developed for precise protein quantification of endogenous proteins in assays application in de novo of protein biomarkers or for of protein of to assay development are the The for this is have in and for of in Dried Blood for and

Topics & Concepts